Drupal.behaviors.print = function(context) {window.print();window.close();}>
Definiens, Cernostics Team on Multiplex Cancer Tests
April 06, 2011
Definiens, Cernostics Team on Multiplex Cancer Tests
Cernostics will use Definiens' Tissue Studio digital pathology technology to develop the tests.
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Metamark, Definiens Partner on Cancer Dx
June 30, 2011 / GenomeWeb Daily News
Cenix, Debiopharm Ink Biomarker ID Deal
May 23, 2013 / GenomeWeb Daily News
Seegene, Selventa Partner on MDx Development for 'Underserved Markets'
April 23, 2013 / GenomeWeb Daily News
CollabRx, Sengenics Partner on Cancer Diagnostics
April 9, 2013 / GenomeWeb Daily News
CollabRx, OncoDNA Combining Technologies for Cancer Mutation Panels
April 4, 2013 / GenomeWeb Daily News